tert-butyl ((1r,4r)-4-(6-methoxy-5-(6-(trifluoromethyl)picolinamido)-2H-indazol-2-yl)cyclohexyl)carbamate CAS 2760376-81-4
New Products
Duloxetine hydrochloride CAS 136434-34-9Duloxetine hydrochloride,136434-34-9,(S)-DULOXETINE HYDROCHLORIDE;LY-248686;DULOXETINE HCL;DULOXETINE HYDROCHLORIDE;N-methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine, hydrochloride;(RS)Duloxetine HCl;(+)-(S)-N-Methyl-g-(1-naphthyloxy)-2-thiophenepropylamine;(gS)-N-Methyl-g-(1-naphthalenyloxy)-2-thiophenepropanamine […]- 2-Isopropylimidazole CAS 36947-68-9Identification […]
- 5-Bromo-6-chloro-1H-indol-3-yl beta-D-glucopyranoside CAS 93863-89-95-Bromo-6-chloro-1H-indol-3-yl beta-D-glucopyranoside,93863-89-9,5-Bromo-6-chloro-3-(beta-D-glucopyranosyloxy)indole ; Magenta glucoside,C14H15BrClNO6 […]
- Fmoc-D-Homoarg(Et)2-OH·HCl CAS 2098497-24-4Identification […]
- Creatine Kinase CAS 9001-15-4Identification […]
- Fluorene CAS 86-73-7Fluorene,86-73-7,Diphenylenemethane ; 2,2'-Methylenebiphenyl ; 2,3-Benzindene ; o-Biphenylenemethane ; alpha-Diphenylenemethane-9H-fluorene,C13H10 […]
- 2,7-Dichlorofluorene CAS 7012-16-02,7-Dichlorofluorene,7012-16-0,,C13H8Cl2 […]
- NADH disodium salt CAS 606-68-8NADH,606-68-8,NADH DISODIUM SALT;NADH;N A D H, REDUCED FORM, DISODIUM;NADH-NA2;NICOTINAMIDE-ADENINE DINUCLEOTIDE (REDUCED) DISODIUM SALT;NICOTINAMIDE ADENINE DINUCLEOTIDE (REDUCED FORM) DISODIUM SALT;eta-d-ribofuranosyl-3-pyridinecarboxamide,disodiumsalt;BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE, REDUCED FORM DISODIUM SALT […]
- Bis(4-tert-butylphenyl)iodonium hexafluorophosphate CAS 61358-25-6Identification […]
- Fluorescein di(beta-D-galactopyranoside) CAS 17817-20-8Fluorescein di(beta-D-galactopyranoside),17817-20-8,,C32H32O15 […]
© 2026 WATSON INTERNATIONAL LIMITED. All Rights Reserved. This site and all content are protected by international Copyright laws. Third party logos and marks appearing on this website are trademarks and/or registered trademarks of their respective owners and licensors, and all rights therein and thereto are reserved to such entities.